Aurinia Pharmaceuticals Stock Forecast - Naive Prediction
| AUPH Stock | USD 15.33 0.69 4.31% |
The Naive Prediction forecasted value of Aurinia Pharmaceuticals on the next trading day is expected to be 14.84 with a mean absolute deviation of 0.28 and the sum of the absolute errors of 17.63. Aurinia Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Aurinia Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 9th of January 2026, The RSI of Aurinia Pharmaceuticals' share price is at 54. This suggests that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Aurinia Pharmaceuticals, making its price go up or down. Momentum 54
Impartial
Oversold | Overbought |
Quarterly Earnings Growth 1.3 | EPS Estimate Next Quarter 0.1533 | EPS Estimate Current Year 0.7817 | EPS Estimate Next Year 0.935 | Wall Street Target Price 16.6667 |
Using Aurinia Pharmaceuticals hype-based prediction, you can estimate the value of Aurinia Pharmaceuticals from the perspective of Aurinia Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Aurinia Pharmaceuticals using Aurinia Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Aurinia using crowd psychology based on the activity and movement of Aurinia Pharmaceuticals' stock price.
Aurinia Pharmaceuticals Short Interest
A significant increase or decrease in Aurinia Pharmaceuticals' short interest from the previous month could be a good indicator of investor sentiment towards Aurinia. Short interest can provide insight into the potential direction of Aurinia Pharmaceuticals stock and how bullish or bearish investors feel about the market overall.
200 Day MA 11.0415 | Short Percent 0.0697 | Short Ratio 5.23 | Shares Short Prior Month 8.4 M | 50 Day MA 15.1577 |
Aurinia Pharmaceuticals Hype to Price Pattern
Investor biases related to Aurinia Pharmaceuticals' public news can be used to forecast risks associated with an investment in Aurinia. The trend in average sentiment can be used to explain how an investor holding Aurinia can time the market purely based on public headlines and social activities around Aurinia Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Aurinia Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Aurinia Pharmaceuticals.
Aurinia Pharmaceuticals Implied Volatility | 0.78 |
Aurinia Pharmaceuticals' implied volatility exposes the market's sentiment of Aurinia Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Aurinia Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Aurinia Pharmaceuticals stock will not fluctuate a lot when Aurinia Pharmaceuticals' options are near their expiration.
The Naive Prediction forecasted value of Aurinia Pharmaceuticals on the next trading day is expected to be 14.84 with a mean absolute deviation of 0.28 and the sum of the absolute errors of 17.63. Aurinia Pharmaceuticals after-hype prediction price | USD 15.33 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Aurinia Pharmaceuticals to cross-verify your projections. Open Interest Against 2026-04-17 Aurinia Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Aurinia Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Aurinia Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Aurinia Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Aurinia Pharmaceuticals' open interest, investors have to compare it to Aurinia Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Aurinia Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Aurinia. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Aurinia Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Aurinia price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aurinia using various technical indicators. When you analyze Aurinia charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Aurinia Pharmaceuticals Cash Forecast
Predicting cash flow or other financial metrics requires analysts to utilize a variety of statistical methods, techniques, and algorithms. These tools help uncover hidden patterns in the Aurinia Pharmaceuticals' financial statements, enabling forecasts of their impact on future stock prices.
Cash | First Reported 1998-12-31 | Previous Quarter 53 M | Current Value 73.2 M | Quarterly Volatility 69.2 M |
Aurinia Pharmaceuticals Naive Prediction Price Forecast For the 10th of January
Given 90 days horizon, the Naive Prediction forecasted value of Aurinia Pharmaceuticals on the next trading day is expected to be 14.84 with a mean absolute deviation of 0.28, mean absolute percentage error of 0.13, and the sum of the absolute errors of 17.63.Please note that although there have been many attempts to predict Aurinia Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Aurinia Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Aurinia Pharmaceuticals Stock Forecast Pattern
| Backtest Aurinia Pharmaceuticals | Aurinia Pharmaceuticals Price Prediction | Buy or Sell Advice |
Aurinia Pharmaceuticals Forecasted Value
In the context of forecasting Aurinia Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Aurinia Pharmaceuticals' downside and upside margins for the forecasting period are 12.24 and 17.43, respectively. We have considered Aurinia Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Aurinia Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Aurinia Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 117.8949 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.2843 |
| MAPE | Mean absolute percentage error | 0.02 |
| SAE | Sum of the absolute errors | 17.629 |
Predictive Modules for Aurinia Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Aurinia Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Aurinia Pharmaceuticals
For every potential investor in Aurinia, whether a beginner or expert, Aurinia Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Aurinia Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Aurinia. Basic forecasting techniques help filter out the noise by identifying Aurinia Pharmaceuticals' price trends.Aurinia Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aurinia Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Aurinia Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Aurinia Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Aurinia Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Aurinia Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Aurinia Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Aurinia Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Aurinia Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aurinia Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Aurinia Pharmaceuticals stock market strength indicators, traders can identify Aurinia Pharmaceuticals entry and exit signals to maximize returns.
| Accumulation Distribution | 72940.74 | |||
| Daily Balance Of Power | (0.66) | |||
| Rate Of Daily Change | 0.96 | |||
| Day Median Price | 15.67 | |||
| Day Typical Price | 15.56 | |||
| Price Action Indicator | (0.69) | |||
| Period Momentum Indicator | (0.69) | |||
| Relative Strength Index | 54.36 |
Aurinia Pharmaceuticals Risk Indicators
The analysis of Aurinia Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Aurinia Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting aurinia stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.86 | |||
| Semi Deviation | 1.86 | |||
| Standard Deviation | 2.58 | |||
| Variance | 6.67 | |||
| Downside Variance | 5.19 | |||
| Semi Variance | 3.47 | |||
| Expected Short fall | (2.22) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether Aurinia Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aurinia Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aurinia Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aurinia Pharmaceuticals Stock:Check out Historical Fundamental Analysis of Aurinia Pharmaceuticals to cross-verify your projections. For more detail on how to invest in Aurinia Stock please use our How to Invest in Aurinia Pharmaceuticals guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aurinia Pharmaceuticals. If investors know Aurinia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aurinia Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.3 | Earnings Share 0.56 | Revenue Per Share | Quarterly Revenue Growth 0.084 | Return On Assets |
The market value of Aurinia Pharmaceuticals is measured differently than its book value, which is the value of Aurinia that is recorded on the company's balance sheet. Investors also form their own opinion of Aurinia Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Aurinia Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aurinia Pharmaceuticals' market value can be influenced by many factors that don't directly affect Aurinia Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aurinia Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aurinia Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aurinia Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.